Nine Square Therapeutics
PrivateLast Round
Grant
Sep 12, 2023
Total Funding Raised
$54.5M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Nine Square Therapeutics is a biotechnology company that develops small-molecule therapeutics for neurodegenerative diseases by integrating machine-learning-enabled image-based cell profiling, chemistry, and computational sciences.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nine Square Therapeutics Comparables
Compare Nine Square Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Libra Therapeutics | 89% | |
| Lysoway Therapeutics | 87% | |
| Casma Therapeutics | 87% | |
Nine Square Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 12, 2023 | ||||
| Series A | Jul 1, 2020 |
Nine Square Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Apple Tree Partners | Series A |
| The Michael J. Fox Foundation for Parkinson's Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors increased 80% MoM.
- Sep 12, 2023
$5M grant from The Michael J. Fox Foundation
Nine Square Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nine Square Therapeutics's valuation, stock price, and market status.